Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
A. B. Saltzman, D. Chan, M. V. Holt…·M. J. Ellis
The paper introduces a kinase inhibitor pulldown assay (KiP) combined with PRM for clinical proteomics, improving kinase quantification in cancer samples.
V. Petrosyan, L. E. Dobrolecki, L. Thistlethwaite…·M. T. Lewis
This paper identifies biomarkers of differential chemotherapy response in TNBC using a network-based approach and validates them in PDX models and clinical datasets.
I. L. Bado, H. Wang, P. Sarkar…·X. H. F. Zhang
The paper shows that the bone microenvironment induces endocrine resistance in ER+ breast cancer metastases through epigenomic reprogramming mediated by EZH2.
N. B. Punturi, S. Seker, V. Devarakonda…·S. Haricharan
This study shows that loss of MLH1, a mismatch repair gene, activates HER2 in ER+/HER2- breast cancer, making these cells sensitive to HER2 inhibitors.
S. Satpathy, E. J. Jaehnig, K. Krug…·M. J. Ellis
This study develops microscaled proteogenomic methods for cancer analysis, showing treatment response and resistance mechanisms in ERBB2-positive breast cancers.
M. J. Ellis, C. N. Tsai, J. W. Johnson…·E. D. Brown
The paper identifies antibacterial compounds effective against intracellular Salmonella Typhimurium through macrophage-based screens and shows metergoline enhances activity by perturbing the bacterial outer membrane.